Kronos Bio Announces Leadership Change with Deborah Knobelman Appointed as President and Interim CEO
Kronos Bio appoints Deborah Knobelman as President and Interim CEO, succeeding Norbert Bischofberger amidst significant workforce reduction.Quiver AI SummaryKronos Bio, Inc. announced that Dr. Deborah...
Kronos Bio Stock Jumps After Deep Workforce Cuts And CEO Shuffle: Retail Aligns With Shake-Up
The company said this move is part of a broader strategy to implement cost-cutting measures.
5 Microcap Stocks With 65% or More Upside Potential
While they do carry higher-than-average risk, these microcaps also offer major upside potential for investors seeking startup-sized returns.